EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - EYPT
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - EYPT
- Market Cap$179.770m
- SymbolNASDAQ:EYPT
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS30233G2093
Company Profile
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed 5 FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Latest EYPT news
Currently there for this company. Visit our news hub for other news .